Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the Akt/GSK-3β Signaling Pathway In Vivo and In Vitro
Marine Drugs · 2023
DOI: 10.3390/md21060329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Dong-Ni Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Drug Target Identification and New Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pekin…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Glioblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, CAMS Innovation Fund for Medical Sciences, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Glioblastoma (GBM) is a major type of primary brain tumor without ideal prognosis and it is therefore necessary to develop a novel compound possessing therapeutic effects. Chrysomycin A (Chr-A) has been reported to inhibit the proliferation, migration and invasion of U251 and U87-MG cells through the Akt/GSK-3β signaling pathway, but the mechanism of Chr-A against glioblastoma in vivo and whether Chr-A modulates the apoptosis of neuroglioma cells is unclear. The present study aims to elucidate the potential of Chr-A against glioblastoma in vivo and how Chr-A modulates the apoptosis of neuroglioma cells. Briefly, the anti-glioblastoma activity was assessed in human glioma U87 xenografted hairless mice. Chr-A-related targets were identified via RNA-sequencing. Apoptotic ratio and caspase 3/7 activity of U251 and U87-MG cells were assayed via flow cytometry. Apoptosis-related proteins and possible molecular mechanisms were validated via Western blotting. The results showed that Chr-A treatment significantly inhibits glioblastoma progression in xenografted hairless mice, and enrichment analysis suggested that apoptosis, PI3K-Akt and Wnt signaling pathways were involved in the possible mechanisms. Chr-A increased the apoptotic ratio and the activity of caspase 3/7 in U251 and U87-MG cells. Western blotting revealed that Chr-A disturbed the balance between Bax and Bcl-2, activating a caspase cascade reaction and downregulating the expression of p-Akt and p-GSK-3β, suggesting that Chr-A may contribute to glioblastoma regression modulating in the Akt/GSK-3β signaling pathway to promote apoptosis of neuroglioma cells in vivo and in vitro. Therefore, Chr-A may hold therapeutic promise for glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Drug Target Identification and New Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
- School of Light Industry, Beijing Technology and Business University, Beijing 100048, China.
- School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
ORCID-Profile: Fu-Hang Song, Hua-Wei Zhang, Yue-Hua Wang
Förderung
- National Key R&D Program of China
- CAMS Innovation Fund for Medical Sciences
- Beijing Natural Science Foundation
Zitieren
APA
Liu, D. N., Liu, M., Zhang, S. S., Shang, Y. F., Zhang, W. F., Song, F. H., Zhang, H. W., Du, G. H., & Wang, Y. H. (2023). Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the Akt/GSK-3β Signaling Pathway In Vivo and In Vitro. Marine Drugs. https://doi.org/10.3390/md21060329
Vancouver
Liu DN, Liu M, Zhang SS, Shang YF, Zhang WF, Song FH, et al. Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the Akt/GSK-3β Signaling Pathway In Vivo and In Vitro. Marine Drugs. 2023. doi:10.3390/md21060329
BibTeX
@article{Liu2023,
author = {Liu, Dong-Ni and Liu, Man and Zhang, Shan-Shan and Shang, Yu-Fu and Zhang, Wen-Fang and Song, Fu-Hang and Zhang, Hua-Wei and Du, Guan-Hua and Wang, Yue-Hua},
title = {Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the Akt/GSK-3β Signaling Pathway In Vivo and In Vitro},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21060329}
}
EUVIMED